The Lead

FDA Raises Safety Concerns for Vivus Diet Pill

February 17, 2012 5:05 am | by MATTHEW PERRONE,AP Health Writer | News | Comments

WASHINGTON (AP) — Federal health officials continue to voice safety concerns about an experimental diet pill from drugmaker Vivus Inc., as the company prepares to make a second attempt to convince experts of the drugs' safety this week.

Orexigen Puts Obesity Drug Development on Hold(2)

June 3, 2011 4:18 am | News | Comments

NEW YORK (AP) — Orexigen Therapeutics Inc. says regulators are making "unprecedented" demands...

Orexigen CFO Cooper Leaving for Personal Reasons(2)

February 17, 2011 5:21 am | News | Comments

Obesity drug developer Orexigen Therapeutics Inc. announced that Chief Financial Officer Graham...

View Sample

FREE Email Newsletter

You may login with either your assigned username or your e-mail address.
The password field is case sensitive.